Balversa- 4mg- US (Erdafitinib Tablet) 4mg

Balversa (erdafitinib) 4mg tablets are a prescription medication used for treating certain types of bladder cancer. This overview covers key details about its uses, effects, and safety considerations for informed decision-making.

Strength

4mg

Manufacturer / TM Owner

Janssen Products LP

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Erdafitinib is primarily used to treat urothelial carcinoma, a type of bladder cancer, in adults whose cancer has spread or cannot be removed by surgery. It belongs to a class of medications called kinase inhibitors, which work by blocking signals that help cancer cells grow. This drug is specifically indicated for patients with specific genetic mutations. It is not a first-line treatment and is used when other options have been exhausted.

Side Effects

Balversa works by targeting specific proteins involved in cancer cell growth, which may slow or stop the progression of bladder cancer. Patients may experience improved symptoms related to their condition, such as reduced pain or discomfort. The effects vary by individual, and regular monitoring by a healthcare provider is essential to assess response and manage any side effects.

Precautions & Warnings

Balversa should be taken exactly as prescribed by a healthcare professional. It is important to discuss your full medical history, including liver or kidney problems, before starting treatment. Regular blood tests are typically required to monitor for potential side effects, such as changes in liver function or phosphate levels. Avoid grapefruit products, as they may interact with the medication.

Avoid Interactions

Erdafitinib can interact with other medications, including strong CYP3A4 inhibitors or inducers, which may affect its effectiveness or increase side effects. Common interacting drugs include certain antifungals, antibiotics, and herbal supplements like St. John’s Wort. Alcohol use should be discussed with a doctor, as it may worsen side effects. Always inform your healthcare provider about all medications and supplements you are taking.

Frequently Asked Questions

Balversa (erdafitinib) is used to treat certain types of bladder cancer in adults, specifically urothelial carcinoma that has spread or cannot be surgically removed.

Balversa should be taken once daily with or without food, as directed by a healthcare provider. Follow the prescribed dosage and do not adjust it without medical advice.

Common side effects may include fatigue, mouth sores, changes in taste, diarrhea, and low phosphate levels. Your doctor will monitor these during treatment.

Alcohol use should be discussed with your doctor, as it may worsen certain side effects like fatigue or nausea. Avoid grapefruit products while taking this medication.

No, Balversa is not a chemotherapy drug. It is a targeted therapy called a kinase inhibitor, which works by blocking specific proteins involved in cancer cell growth.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.